|
|
|
EY's Arda Ural provides an assessment of the current life sciences business environment, and reasons for optimism about 2025 despite the uncertainty that comes with a new administration in the U.S. |
|
|
|
|
|
|
| The Rapid Digitization Of Trials | It’s no secret that more trials are going digital. Hear from a panel of industry experts as they discuss the evolution of digital trials and share their experiences. |
|
|
|
|